Home » Stocks » INIS

International Isotopes Inc. (INIS)

Stock Price: $0.1380 USD -0.0020 (-1.43%)
Updated Jun 18, 2021 3:48 PM EDT - Market closed
Market Cap 63.59M
Revenue (ttm) 9.02M
Net Income (ttm) 2.02M
Shares Out 460.83M
EPS (ttm) 0.01
PE Ratio 27.60
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 18
Last Price $0.1380
Previous Close $0.1400
Change ($) -0.0020
Change (%) -1.43%
Day's Open 0.1380
Day's Range 0.1325 - 0.1470
Day's Volume 197,287
52-Week Range 0.0430 - 0.2095

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

IDAHO FALLS, Idaho, May 18, 2021 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company") is pleased to announce its financial results for the three months ended March 31, 2021. Revenue...

1 month ago - PRNewsWire

IDAHO FALLS, Idaho, March 31, 2021 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company") announces its financial results for the fiscal year ended December 31, 2020.  Total revenues ...

2 months ago - PRNewsWire

IDAHO FALLS, Idaho, Jan. 26, 2021 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company") is pleased to announce the following developments. International Isotopes recently signed a di...

4 months ago - PRNewsWire

IDAHO FALLS, Idaho, Jan. 21, 2021 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company"), due to recent unusual trading volume, and share price volatility in its common stock, is prov...

4 months ago - PRNewsWire

About INIS

International Isotopes, Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, and radiopharmaceutical and radiochemical contract manufacturing services in the United States and internationally. It operates through four segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, and Radiological Services. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed and positron emission tomography imaging, patient posit... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
IPO Date
Aug 14, 1997
Stock Exchange
OTCMKTS
Ticker Symbol
INIS
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for INIS is 0.12, which is a decrease of -13.04% from the latest price.

Price Target
$0.12
(-13.04% downside)